DCH Health System Announces Launch of Donor Breast Milk Program
DCH Health System announces the launch of a donor breast milk program benefiting premature infants in the neonatal intensive care units (NICUs) at DCH Regional Medical Center and Northport Medical Center.
DCH has been a pioneer in providing exclusive human milk nutrition for premature infants in its NICUs and is already using fortifiers made from human milk, as opposed to cow milk. DCH will partner with Prolacta Bioscience to establish the Human Milk Program at DCH Health System. The program uses surplus breast milk of nursing mothers in their community to make standardized donor breast milk, made by Prolacta Bioscience. The milk will be distributed to premature infants hospitalized across the country, including the NICUs at both Tuscaloosa County hospitals.
“This is an easy and safe outlet for mothers to donate their unused breast milk to babies who need it the most,” said Lorraine Yehlen, vice president of patient care services for the DCH Health System. “We will now be able to provide what is ‘Best for Baby,’ and the only available standardized donor milk that has a precise amount of calories and protein, enabling targeted nutrition to help ensure appropriate growth of our most fragile premature infants.”
Prolacta will manage the qualification process of moms referred from DCH with health screenings and blood testing, along with streamlining the milk collection and shipping process right from moms’ homes. Prolacta’s high-tech manufacturing facility will be used to conduct the safety and quality testing before pasteurizing the human milk products for in-hospital use.
“For moms, this will come as a welcome option, since many struggle with what to do with their extra breast milk,” Yehlen said. “With the help of Prolacta, they will now be able to support premature infants right in their own community.”
To learn how to become a donor, visit click here.
ABOUT PROLACTA BIOSCIENCE
Prolacta Bioscience, Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. The company pioneered the development of human milk-based neonatal nutritional products to meet the needs of critically ill, premature infants in the NICU. Prolacta leads the industry in the quality and safety of nutritional products made from breast milk and operates the first and only pharmaceutical-grade manufacturing facility for the processing of human breast milk. For more information please visit www.prolacta.com